Clinical
MASH
Metabolic dysfunction-associated steatohepatitis — the updated term for NASH.
Definition
MASH (formerly NASH) is a progressive form of fatty liver disease featuring inflammation and fibrosis. Incretin peptides reduce MASH in clinical trials; retatrutide Phase II showed ~80% MASH resolution.
Back to the full peptide glossary.